Supplier
Kilgore INC
Kilgore INC was paid $1.60M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is J7503, Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg — 50% of everything it billed.
33Billing provider infoKILGORE INC
COLUMBIA, MO 65203
COLUMBIA, MO 65203
33aNPI1417901646assigned 05/20/2006
33bProvider typeCompounding Pharmacy
28Total paid$1.60M
24GClaims120,982
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Compounding Pharmacy providers in Missouri
Rank by total paid#1 of 12
Median peer was paid$51K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,138 | $232K | |
| 2019 | 21,073 | $214K | |
| 2020 | 22,882 | $295K | |
| 2021 | 19,491 | $290K | |
| 2022 | 16,271 | $243K | |
| 2023 | 13,621 | $207K | |
| 2024incomplete | 10,506 | $118K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 50% | 7,484 | 6,157 | $794K |
| J7518 | Mycophenolic acid, oral, 180 mg | 25% | 12,748 | 11,284 | $398K |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 9.0% | 14,700 | 11,702 | $144K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 5.2% | 22,425 | 20,734 | $83K |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 3.8% | 37,933 | 20,134 | $61K |
| J7500 | Azathioprine, oral, 50 mg | 3.5% | 1,685 | 1,536 | $55K |
| J7517 | Mycophenolate mofetil, oral, 250 mg | 1.4% | 2,219 | 2,024 | $23K |
| T2029 | Specialized medical equipment, not otherwise specified, waiver | 1.3% | 216 | 208 | $21K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 19,525 | 17,825 | $6K |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | <1% | 603 | 565 | $5K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | <1% | 1,016 | 939 | $5K |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | <1% | 69 | 50 | $2K |
5 more codes
| A5512 | For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each | <1% | 27 | $942.53 |
| J7515 | Cyclosporine, oral, 25 mg | <1% | 54 | $457.81 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 62 | $242.32 |
| J7502 | Cyclosporine, oral, 100 mg | <1% | 13 | $132.24 |
| A4259 | Lancets, per box of 100 | <1% | 203 | $81.85 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROMSTEDT, ANN (OWNER)